CMS Unveils Proposals to Enhance Oversight of Accrediting Organizations and Expand Texting for Patient Care Orders

The Centers for Medicare & Medicaid Services (CMS) recently revealed significant updates aimed at improving oversight and transparency in healthcare. As part of the Inflation Reduction Act, CMS conducted patient-focused listening sessions regarding the Medicare Drug Price Negotiation Program.

These sessions, covering 10 selected drugs under Medicare Part D, allowed stakeholders to provide valuable input. Discussions took place between late October and mid-November 2023, fostering dialogue between patients, caregivers, and advocacy groups.

A new policy permitting the texting of patient orders was also implemented by CMS. This initiative allows hospitals and Critical Access Hospitals to use secure platforms for text orders, following HIPAA regulations to protect patient privacy.

In a push for accountability, CMS announced a proposed rule to enhance oversight of Accrediting Organizations (AOs). AOs, responsible for accrediting thousands of healthcare providers, must adhere to strict standards and avoid conflicts of interest.

Under the proposed rule, AOs will be required to align their survey activities and staff training with state Survey Agencies. Those with subpar performance will need to submit correction plans publicly to CMS, promoting a more transparent and high-quality healthcare system.

CMS remains committed to advancing health equity and improving outcomes for all Americans. As a vital agency within the U.S. Department of Health and Human Services, CMS plays a crucial role in safeguarding public health and ensuring access to quality healthcare services.

Stay updated on CMS news by visiting their official website, subscribing to their newsletters, and following them on social media platforms like Twitter.